Patents by Inventor Miho Kato
Miho Kato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11911420Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.Type: GrantFiled: January 31, 2019Date of Patent: February 27, 2024Assignee: NUTRI CO., LTD.Inventors: Susumu Kawaguchi, Miho Kato
-
Patent number: 11914248Abstract: An object of the invention is to provide a photo-alignment copolymer which makes it possible to produce a photo-alignment film having excellent solvent resistance and liquid crystal aligning properties, and a photo-alignment film and an optical laminate produced using the photo-alignment copolymer. A photo-alignment copolymer of the invention is a photo-alignment copolymer having a repeating unit A including a photo-alignment group represented by Formula (A) and a repeating unit B including a crosslinkable group represented by Formula (B).Type: GrantFiled: November 8, 2020Date of Patent: February 27, 2024Assignee: FUJIFILM CorporationInventors: Yutaka Nozoe, Takashi Iizumi, Kazushige Nakagawa, Takahiro Kato, Miho Asahi, Hirofumi Omura, Yuki Hirai
-
Publication number: 20230320225Abstract: A piezoelectric element includes a piezoelectric body, an external electrode, and an internal electrode. The internal electrode includes first and second internal conductors opposing each other. The first internal conductor includes first and second conductor portions continuous with each other. The second internal conductor includes a third conductor portion opposing the first conductor portion in a direction where the first and second internal conductors oppose each other, and a fourth conductor portion including a first region connected to the second conductor portion, and a second region continuous with the first region and continuous with the third conductor portion. The piezoelectric body includes a body portion located between the first and the second internal conductors, and formed with a through hole penetrating the body portion in the direction. The fourth conductor portion is located in the through hole and has a thickness increasing toward a center line of the through hole.Type: ApplicationFiled: March 13, 2023Publication date: October 5, 2023Applicant: TDK CorporationInventors: Hiroki MITSUI, Hideya Sakamoto, Yoshiki Ohta, Miho Kato, Hiroyuki Ijiri, Akihiro Takeda
-
Patent number: 11730776Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.Type: GrantFiled: October 4, 2019Date of Patent: August 22, 2023Assignee: NUTRI CO., LTD.Inventors: Susumu Kawaguchi, Miho Kato
-
Publication number: 20220209096Abstract: The vibration device includes a piezoelectric element having a connection terminal exposed from a main surface of the piezoelectric element, a first resin layer having conductivity and covering the connection terminal of the piezoelectric element to be electrically connected to the connection terminal, a wiring member overlapping the main surface of the piezoelectric element to cover the first resin layer, including a wire electrically connected to the first resin layer, and extending beyond one end of the piezoelectric element when viewed in a thickness direction of the piezoelectric element, and a second resin layer integrally covering the main surface of the piezoelectric element and the wiring member. The second resin layer includes a first layer in direct contact with the piezoelectric element and the wiring member, and a second layer covering the piezoelectric element and the wiring member via the first layer.Type: ApplicationFiled: November 22, 2021Publication date: June 30, 2022Applicant: TDK CORPORATIONInventors: Keisuke TERANISHI, Hiroki MITSUI, Miho KATO, Hideya SAKAMOTO, Narumi SATO
-
Publication number: 20210386797Abstract: Provided is a novel prophylactic and/or therapeutic agent for Clostridium difficile infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Clostridium difficile infection. The prophylactic and/or therapeutic agent for Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Clostridium difficile infection, comprising a bacterium belonging to the genus Enterococcus.Type: ApplicationFiled: October 4, 2019Publication date: December 16, 2021Applicant: Nutri Co., Ltd.Inventors: Susumu Kawaguchi, Miho Kato
-
Publication number: 20210379124Abstract: Provide is a novel prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Streptococcus pneumoniae infection. The prophylactic and/or therapeutic agent for Streptococcus pneumoniae infection, comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus; and a food for prevention and/or treatment of Streptococcus pneumoniae infection, comprising a bacterium belonging to the genus Enterococcus.Type: ApplicationFiled: January 31, 2019Publication date: December 9, 2021Applicant: Nutri Co., Ltd.Inventors: Susumu Kawaguchi, Miho Kato
-
Patent number: 10960034Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection. The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.Type: GrantFiled: January 25, 2018Date of Patent: March 30, 2021Assignee: NUTRI CO., LTD.Inventors: Susumu Kawaguchi, Miho Kato
-
Publication number: 20200405784Abstract: Provided is a novel prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection. It was found that a bacterium belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. The prophylactic and/or therapeutic agent for Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A medicine for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus. A food for prevention and/or treatment of Pseudomonas aeruginosa infection, comprising a bacterium belonging to the genus Enterococcus.Type: ApplicationFiled: April 17, 2019Publication date: December 31, 2020Applicant: Nutri Co., Ltd.Inventors: Susumu Kawaguchi, Miho Kato
-
Publication number: 20190374586Abstract: Provided is a novel MRSA infection protective agent. Bacteria belonging to the genus Enterococcus have been found to be capable of protecting against MRSA infection, The MRSA infection protective agent comprises a bacterium belonging to the genus Enterococcus. Also provided are: a medicine for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus; and a food for protection against MRSA infection, comprising a bacterium belonging to the genus Enterococcus.Type: ApplicationFiled: January 25, 2018Publication date: December 12, 2019Applicant: Nutri Co., Ltd.Inventors: Susumu KAWAGUCHI, Miho KATO
-
Patent number: 10379832Abstract: A device includes a processor that performs a procedure.Type: GrantFiled: March 9, 2017Date of Patent: August 13, 2019Assignee: FUJITSU LIMITEDInventors: Tomoyuki Onda, Takahisa Hatakeyama, Miho Kato, Kazumi Sasae, Ayano Koike
-
Publication number: 20170262269Abstract: A device includes a processor that performs a procedure.Type: ApplicationFiled: March 9, 2017Publication date: September 14, 2017Applicant: FUJITSU LIMITEDInventors: Tomoyuki Onda, Takahisa Hatakeyama, Miho Kato, KAZUMI SASAE, Ayano Koike
-
Patent number: 9323642Abstract: A calculation method includes calculating, by a processor, a difference between a first value and a second value, the first value being read from a clock counter that counts pulses of a clock signal having a plurality of types of frequencies, supplied to the processor in response to control command to start processing for an unit to be allocated to the processor, the second value being read from the clock counter in response to control command to stop processing.Type: GrantFiled: December 7, 2012Date of Patent: April 26, 2016Assignee: FUJITSU LIMITEDInventors: Miho Kato, Hiroyuki Suzuki, Tsubasa Kitayama, Norio Kurobane
-
Publication number: 20030087949Abstract: The invention provides a compound represented by the following formula (I) useful for inhibiting death of cells, the drug being expected as a preventive or a remedy for the progress of various diseases wherein cell death participates in progress and exacerbation thereof: 1Type: ApplicationFiled: September 26, 2002Publication date: May 8, 2003Inventors: Mikiko Sodeoka, Miho Kato, Rei Asakai